Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • schelhorn
    Member
    • Sep 2010
    • 10

    #1

    Offering a user-paid NGS analysis pipeline in the cloud

    Dear Community,

    our lab has developed a NGS analysis pipeline for viral sequence analysis (both genomic resequencing and RNA-Seq, including some novel pathogen detection and viral quasi-species reconstruction approaches) that fulfills various analytical needs of our clinical cooperation partners. Since we believe that the pipeline might be of interest to the broader virological community we decided to integrate our workflow into Galaxy as a set of plugins.

    However, we do need our in-house computational capacities for our own analyses and are targeting people who do not have time and experience to set up their own Galaxy installation (for example, clinical virologists). Therefore we would like to provide the finished product as a non-profit service in the cloud (for example, by using Amazon AWS, for which the Galaxy installation is pretty straightforward).

    We envision (or at least, hope) that the pipeline will be used heavily and would therefore like to transfer the costs for the used resources to the user (e.g., the clinical virologist) in a pay-as-you-go manner. Amazon offers its 'DevPay' service for these purpose, basically an infrastructure to bill users of an AWS application instead of the application provider. Again, we do not want to make any profit with this service, we just want people to pay for the cpu cycles they burn with as few hassles for us as possible.

    I could well imagine that other academic institutions have similar goals, e.g. being willing to offer their work for free without wanting to cover the costs for analysis resources. Does anyone have experience with similar kinds of setups and would like to offer advice? I am looking for hints about technical (e.g. how to best integrate a Cloud Galaxy with DevPay or similar) as well as legal hurdles that we might have to be careful about (e.g., are we in conflict with open-source software licenses if billing is involved, even if we do not make a profit etc.).

    Thanks a bunch!

    Sven
    Last edited by schelhorn; 08-25-2011, 02:08 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
61 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
77 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Working...